Control of HIV-1 infection by soluble factors of the immune response.
DeVico
Anthony L
AL
Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, Maryland 21202, USA. gallo@umbi.umd.edu
Gallo
Robert C
RC
D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D054407:Chemokine CCL4; D018946:Chemokine CCL5 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D019402:Macrophage Inflammatory Proteins / Q000276:immunology*; D051379:Mice; D014779:Virus Replication / Q000276:immunology
D054407:Chemokine CCL4; D018946:Chemokine CCL5; D019402:Macrophage Inflammatory Proteins